|
Volumn 40, Issue 5, 2004, Pages 965-970
|
Pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis: Safety and feasibility study
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FIBRINOLYTIC AGENT;
RETEPLASE;
TISSUE PLASMINOGEN ACTIVATOR;
UROKINASE;
ADULT;
AGED;
ANGIOPLASTY;
ARTICLE;
BIOSAFETY;
CATHETER;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DEEP VEIN THROMBOSIS;
DISEASE SEVERITY;
FEASIBILITY STUDY;
FEMALE;
FIBRINOLYTIC THERAPY;
FOLLOW UP;
HUMAN;
LEG;
MALE;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
RECURRENT DISEASE;
REOPERATION;
STENT;
THROMBECTOMY;
TREATMENT INDICATION;
TREATMENT OUTCOME;
VASCULAR PATENCY;
ADULT;
AGED;
COMBINED MODALITY THERAPY;
FEASIBILITY STUDIES;
FEMALE;
FIBRINOLYTIC AGENTS;
FOLLOW-UP STUDIES;
HUMANS;
LOWER EXTREMITY;
MALE;
MIDDLE AGED;
PHLEBOGRAPHY;
RISK ASSESSMENT;
SAFETY;
SAMPLING STUDIES;
SEVERITY OF ILLNESS INDEX;
SURVIVAL RATE;
THROMBECTOMY;
THROMBOLYTIC THERAPY;
TREATMENT OUTCOME;
VENOUS THROMBOSIS;
|
EID: 8844280874
PISSN: 07415214
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jvs.2004.08.025 Document Type: Article |
Times cited : (128)
|
References (10)
|